Researchers at Johns Hopkins University have developed digital twins of patients' hearts to improve treatment for ventricular tachycardia, showing promising results in a recent clinical trial. Business Wire: Thermedical Awarded $3 Million NIH Grant to Study Promising Treatment for Ventricular Tachycardia, a Leading Cause of Sudden Cardiac Death Thermedical Awarded $3 Million NIH Grant to Study Promising Treatment for Ventricular Tachycardia, a Leading Cause of Sudden Cardiac Death Johns Hopkins researchers have created digital twins of patients' hearts, enhancing treatment for ventricular tachycardia. Initial trials show promising results, indicating a potential shift in ...
About 2 million Americans have a heart condition called “ paroxysmal supraventricular tachycardia ,” or PSVT. An electrical problem in the heart causes it to beat very fast—150-220 beats per ... The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Landiolol is a selective beta-1 adrenergic ...
treatment for tachycardia, Scientists have developed precise virtual replicas of patients' hearts, aiding doctors in treating ventricular tachycardia, a major cause of sudden cardiac arrest. Times Now on MSN: Innovative digital twins enhance treatment for irregular heartbeat
